Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To estimate the effectiveness of the combination of Oxaliplatino and Capecitabine (XELOX-2) + bevacizumab measured in terms of objective response rate in non treaty advanced colorectal cancer treatment.
Critère d'inclusion
- Oncologic patients